{
    "info": {
        "nct_id": "NCT00654420",
        "official_title": "An Open Label, Randomized Phase I/IIa Trial Evaluating MK-0646 in Combination With Erlotinib (TARCEVAâ„¢) for Patients With Recurrent Non-Small Cell Lung Cancer",
        "inclusion_criteria": "* Participant has locally advanced or metastatic stage IIIB/IV NSCLC that has relapsed after hemotherapy/chemoratiotherapy\n* Participant has had at least one chemotherapy regimen for recurrent or metastatic disease\n* Participant is 18 years of age or older\n* Participant has a performance status of 0-2 on Eastern Cooperative Group (ECOG) scale\n* Women of childbearing potential have a negative pregnancy test\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Participant has had chemotherapy within 2 weeks or biological therapy (e.g. bevacizumab) within 4 weeks\n* Participant has not recovered from adverse events from previous therapy within 4 weeks\n* Participant has received EGFR-Tyrosine Kinase Inhibitor (TKI) inhibitor/anti-EGFR mAb therapy\n* Participant has received IGF1R-TKI inhibitor/anti-IGF1R mAB therapy\n* Participant has had more than 2 systemic chemotherapies for metastatic disease\n* Participant has not completed radiotherapy with complete resolution of toxicities at least 2 weeks before starting in the study\n* Participant is taking part in another clinical study\n* Participant has a primary central nervous system tumor\n* Participant abuses drugs or alcohol\n* Participant is pregnant or breastfeeding\n* Participant is Human Immunodeficiency Virus (HIV) positive\n* Participant has a history of hepatitis B or C\n* Participant is using growth hormone or growth hormone inhibitors",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Participant has locally advanced or metastatic stage IIIB/IV NSCLC that has relapsed after hemotherapy/chemoratiotherapy",
            "criterions": [
                {
                    "exact_snippets": "locally advanced or metastatic stage IIIB/IV NSCLC",
                    "criterion": "NSCLC stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "IIIB",
                                "IV"
                            ]
                        },
                        {
                            "requirement_type": "condition",
                            "expected_value": [
                                "locally advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "relapsed after hemotherapy/chemoratiotherapy",
                    "criterion": "NSCLC treatment history",
                    "requirements": [
                        {
                            "requirement_type": "relapse",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "previous treatments",
                            "expected_value": [
                                "chemotherapy",
                                "chemoradiotherapy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has had at least one chemotherapy regimen for recurrent or metastatic disease",
            "criterions": [
                {
                    "exact_snippets": "Participant has had at least one chemotherapy regimen",
                    "criterion": "chemotherapy regimen",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "regimen"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "recurrent or metastatic disease",
                    "criterion": "disease type",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": [
                                "recurrent",
                                "metastatic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant is 18 years of age or older",
            "criterions": [
                {
                    "exact_snippets": "Participant is 18 years of age or older",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has a performance status of 0-2 on Eastern Cooperative Group (ECOG) scale",
            "criterions": [
                {
                    "exact_snippets": "performance status of 0-2 on Eastern Cooperative Group (ECOG) scale",
                    "criterion": "performance status",
                    "requirements": [
                        {
                            "requirement_type": "scale",
                            "expected_value": "Eastern Cooperative Group (ECOG)"
                        },
                        {
                            "requirement_type": "range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women of childbearing potential have a negative pregnancy test",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential ... negative pregnancy test",
                    "criterion": "pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "volunteer health status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "healthy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Participant has had chemotherapy within 2 weeks or biological therapy (e.g. bevacizumab) within 4 weeks",
            "criterions": [
                {
                    "exact_snippets": "Participant has had chemotherapy within 2 weeks",
                    "criterion": "chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "biological therapy (e.g. bevacizumab) within 4 weeks",
                    "criterion": "biological therapy",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has not recovered from adverse events from previous therapy within 4 weeks",
            "criterions": [
                {
                    "exact_snippets": "Participant has not recovered from adverse events from previous therapy within 4 weeks",
                    "criterion": "recovery from adverse events",
                    "requirements": [
                        {
                            "requirement_type": "time since previous therapy",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has received EGFR-Tyrosine Kinase Inhibitor (TKI) inhibitor/anti-EGFR mAb therapy",
            "criterions": [
                {
                    "exact_snippets": "Participant has received EGFR-Tyrosine Kinase Inhibitor (TKI) inhibitor",
                    "criterion": "EGFR-Tyrosine Kinase Inhibitor (TKI) therapy",
                    "requirements": [
                        {
                            "requirement_type": "receipt",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Participant has received ... anti-EGFR mAb therapy",
                    "criterion": "anti-EGFR mAb therapy",
                    "requirements": [
                        {
                            "requirement_type": "receipt",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has received IGF1R-TKI inhibitor/anti-IGF1R mAB therapy",
            "criterions": [
                {
                    "exact_snippets": "Participant has received IGF1R-TKI inhibitor",
                    "criterion": "IGF1R-TKI inhibitor therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Participant has received ... anti-IGF1R mAB therapy",
                    "criterion": "anti-IGF1R mAB therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has had more than 2 systemic chemotherapies for metastatic disease",
            "criterions": [
                {
                    "exact_snippets": "Participant has had more than 2 systemic chemotherapies for metastatic disease",
                    "criterion": "systemic chemotherapies for metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has not completed radiotherapy with complete resolution of toxicities at least 2 weeks before starting in the study",
            "criterions": [
                {
                    "exact_snippets": "Participant has not completed radiotherapy",
                    "criterion": "radiotherapy completion",
                    "requirements": [
                        {
                            "requirement_type": "completion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "complete resolution of toxicities",
                    "criterion": "resolution of toxicities",
                    "requirements": [
                        {
                            "requirement_type": "resolution",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 2 weeks before starting in the study",
                    "criterion": "time since radiotherapy completion",
                    "requirements": [
                        {
                            "requirement_type": "time since completion",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant is taking part in another clinical study",
            "criterions": [
                {
                    "exact_snippets": "Participant is taking part in another clinical study",
                    "criterion": "participation in another clinical study",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has a primary central nervous system tumor",
            "criterions": [
                {
                    "exact_snippets": "primary central nervous system tumor",
                    "criterion": "primary central nervous system tumor",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant abuses drugs or alcohol",
            "criterions": [
                {
                    "exact_snippets": "Participant abuses drugs",
                    "criterion": "drug abuse",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Participant abuses ... alcohol",
                    "criterion": "alcohol abuse",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant is pregnant or breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "Participant is pregnant",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant is Human Immunodeficiency Virus (HIV) positive",
            "criterions": [
                {
                    "exact_snippets": "Participant is Human Immunodeficiency Virus (HIV) positive",
                    "criterion": "HIV status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": "positive"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant has a history of hepatitis B or C",
            "criterions": [
                {
                    "exact_snippets": "history of hepatitis B",
                    "criterion": "hepatitis B",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of ... C",
                    "criterion": "hepatitis C",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant is using growth hormone or growth hormone inhibitors",
            "criterions": [
                {
                    "exact_snippets": "Participant is using growth hormone",
                    "criterion": "growth hormone usage",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Participant is using ... growth hormone inhibitors",
                    "criterion": "growth hormone inhibitor usage",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}